News
Emily Mason-Osann Receives PhRMA Foundation Pre Doctoral Fellowship
Emily Mason-Osann, a fourth year Ph.D. student in the Program in Biomolecular Pharmacology, has received a pre doctoral fellowship in pharmacology/toxicology from the PhRMA Foundation. The research proposed is titled, “Defining Mechanism and Therapeutic Targets in the Alternative Lengthening of the Telomeres Pathway.” She is pursuing her thesis research under the mentorship of Rachel L. […]
Dr. Wendy Qiu is corresponding author on BU Alzheimer’s Study Examining the Role of Inflammation in Alzheimer’s Disease
As reported in the Friday, October 19, 2018 edition of The Boston Globe, Boston University researchers published results of their study on the examining the role of inflammation in Alzheimer’s disease in the journal JAMA Network Open. Per the abstract, the research objective was “To study the interaction between the apolipoprotein E (ApoE) genotype and […]
November 16, 2018 BU Pharmacology-Biogen Symposium: Innovations in Neuroscience Discovery
Innovations in Neuroscience Drug Discovery Friday, November 16th 2018, 8:00 a.m. – 6:30 p.m. BU Pharmacology & Experimental Therapeutics – Biogen Symposium Biogen, 300 Binney Street, Cambridge, MA 02142 Free and open to the public. REGISTRATION Registration has now closed. There is no onsite registration. BU-Biogen Symposium booklet_20181107_230pm LOCATION/PARKING MAP Registration and Breakfast David H. […]
Dr. Hui Feng Named 2018 Arden Quinn Bucher Memorial Fund St. Baldrick’s Foundation Scholar
Dr. Hui Feng has been named the 2018 Arden Quinn Bucher Memorial Fund St. Baldrick’s Foundation Scholar. This award was established in memory of Arden Quinn Bucher who was diagnosed with neuroblastoma in 2007 at the age of 2. An amplified gene, MYCN, is found in ~30% of neuroblastomas, and is associated with highly aggressive […]
WBUR Interview-Dr. Richard Wainford on Salt-Sensitive Gene Discovery
Dr. Richard Wainford spoke with Carey Goldberg on WBUR today regarding his study connecting salt sensitivity to mutations in the GNAI2 gene. He noted that 1 in 2 adults in the U.S. have high blood pressure and, according to this study, “if you have this mutation . . . you’re three times more likely to […]
Drs. Karen Harnett and Neil Ganem Honored as 2018 BUSM Educators of the Year
Karen Harnett, Ph.D., Assistant Professor of Pharmacology, and Neil J. Ganem, Ph.D., Assistant Professor of Pharmacology and Medicine, Section of Hematology and Medical Oncology are among the nine recipients of 2018 BUSM Educator of the Year honors. Faculty were nominated for awards in each category by medical students and Division of Graduate Medical Sciences students. […]
David Waxman Receives The Bernard B. Brodie Award in Drug Metabolism for Research on Sex Differences in Drug Metabolism
David J. Waxman, Ph.D., Boston University Professor of Cell and Molecular Biology and Medicine, was awarded the Bernard B. Brodie Award in Drug Metabolism by the American Society for Pharmacology and Experimental Therapeutics (ASPET) at their 2018 annual meeting in San Diego, California. The award was presented to Dr. Waxman for his research on “Sex […]
Andrieu and Denis paper featured as Editor’s Pick/Cover Story in April 2018 Issue of Molecular Cancer Research
A paper by Boston University investigators, Guillaume Andrieu, Ph.D. and Gerald V. Denis, Ph.D., has been selected as the Cover Story and Editor’s Pick for Rapid Impact in the April 2018 Issue of Molecular Cancer Research. BET Proteins Exhibit Transcriptional Function Opposition in the Epithelial-to-Mesenchymal Transition reports on research carried out on inhibitors of the […]
Dr. Zhen Jiang’s New C2 Domain Discovery in April Molecular and Cell Biology’s “Selected as Article of Significant Interest . . . by the Editors”
Zhen Y. Jiang, M.D., Ph.D., and his research group, have discovered a new C2 domain containing phosphoprotein CDP138 that is important for membrane trafficking. Membrane Trafficking Protein CDP138 Regulates Fat Browning and Insulin Sensitivity through Controlling Catecholamine Release in the April 2018 edition of Molecular and Cellular Biology and featured in Articles of Significant Interest Selected […]
Marc Vittoria Receives NCI F30 Ruth L. Kirschstein NRSA Award
Marc Vittoria, M.D./Ph.D. Graduate Student in the Program in Biomolecular Pharmacology, has been awarded an F30 Ruth L. Kirschstein National Research Service Award from the National Cancer Institute. Marc’s thesis research, “Defining Novel Mechanisms of Genome Instability in BRAF-mutant Melanoma,” is being carried out in the Laboratory of Cancer Cell Biology under the mentorship of […]